BackRydex Biotechnology Inv Overview

Rydex Biotechnology Inv Current Cash

Rydex Biotechnology Inv's current cash is $28M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$28.50M
↓ 60.70% YoYΔ $-44.00M vs prior year quarter

Peer trimmed avg / median

Loading

Rydex Biotechnology Inv Current Cash History

Loading

Rydex Biotechnology Inv vs. peers: Current Cash Comparison

Loading

Rydex Biotechnology Inv Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rydex Biotechnology Inv (RYOIX) FAQ

As of the most recent data (December 2023), RYOIX shows a current cash of $28M. That compares with $72M in the prior-year period — down 60.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RYOIX's current cash is now $28M (was $72M) — a 60.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Rydex Biotechnology Inv is outperforming or lagging.

Tracking RYOIX's current cash over time shows whether Rydex Biotechnology Inv is scaling, shrinking, or reshaping that part of the business. The current reading is $28M That compares with $72M in the prior-year period — down 60.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Rydex Biotechnology Inv's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $28M) with ownership activity and broader fundamentals.

Questions & Answers